Once a Covid-19 vaccine hits the market it will need to be widely distributed, and companies like FedEx stand to benefit, Citi said Thursday while reiterating its buy rating on the stock.
In a note to clients titled “stars aligning” the firm raised its price target on the stock to a Street high of $235, which is about 17% above where the stock currently trades. The firm’s prior forecast was $170….

Click here to view the original article.